Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.99 CHF 3.69%
Market Cap: CHf370.9m
Write Note Create Alert Ask AI

Wall St Price Targets

MEDX Price Targets Summary
Medmix Ltd

Wall Street analysts forecast MEDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDX is 15.71 CHF with a low forecast of 13.64 CHF and a high forecast of 16.8 CHF.

MEDX Lowest Forecast
Wall Street Target
CHf13.64
52% Upside
MEDX Average Forecast
Wall Street Target
CHf15.71
75% Upside
MEDX Highest Forecast
Wall Street Target
CHf16.8
87% Upside
Lowest Forecast
Price Target
13.64 CHF
52% Upside
Average Forecast
Price Target
15.71 CHF
75% Upside
Highest Forecast
Price Target
16.8 CHF
87% Upside
Medmix Ltd Competitors:
Price Targets

Revenue
Forecast

1% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
1% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 5%.

What are analyst estimates?

Gross Profit
Forecast

0% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
0% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 5%.

What are analyst estimates?

Operating Income
Forecast

-10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
-10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 6 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 8 years is 11%.

What are analyst estimates?

Pre-Tax Income
Forecast

-19% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-55%
Average Miss
-19% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-55%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been -19%. The projected CAGR for the next 3 years is 50%.

What are analyst estimates?

Net Income
Forecast

-20% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-63%
Average Miss
-20% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-63%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been -20%. The projected CAGR for the next 3 years is 54%.

What are analyst estimates?

Continue MEDX Research

Summary
MEDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDX stock valuation using valuation multiples.
Wall St Estimates
MEDX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MEDX's stock price target?
Price Target
15.71 CHF

According to Wall Street analysts, the average 1-year price target for MEDX is 15.71 CHF with a low forecast of 13.64 CHF and a high forecast of 16.8 CHF.

What is the Revenue forecast for Medmix Ltd?
Projected CAGR
5%

Over the last 6 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for Medmix Ltd?
Projected CAGR
5%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Medmix Ltd?
Projected CAGR
11%

Over the last 6 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 8 years is 11%.

What is the Pre-Tax Income forecast for Medmix Ltd?
Projected CAGR
50%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been -19%. The projected CAGR for the next 3 years is 50%.

What is the Net Income forecast for Medmix Ltd?
Projected CAGR
54%

Over the last 6 years, the compound annual growth rate for Net Income has been -20%. The projected CAGR for the next 3 years is 54%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.